| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/08/1999 | CA2242308A1 Novel compounds |
| 06/03/1999 | WO1999027111A1 Desaturase genes and their use |
| 06/03/1999 | WO1999027098A2 A-33 related antigens and their pharmacological uses |
| 06/03/1999 | WO1999026945A1 1,3,4-THIADIAZOLES AND 1,3,4-OXADIAZOLES AS αvβ3 ANTAGONISTS |
| 06/03/1999 | WO1999026921A1 SUBSTITUTED β-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS |
| 06/03/1999 | WO1999026659A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor |
| 06/03/1999 | WO1999026638A1 Reducing blood cholesterol by in vivo precipitation of bile constituents with group ii or -iii metal substances |
| 06/03/1999 | WO1999026606A2 SUSTAINED RELEASE FORMULATIONS COMPRISING α-GLUCOSIDASE-INHIBITORS |
| 06/03/1999 | WO1999026583A2 Inhibtion of lipoprotein oxidation |
| 06/03/1999 | WO1999012566A9 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 06/03/1999 | WO1999007729A3 Peptides having potassium channel opener activity |
| 06/03/1999 | CA2311472A1 Desaturase genes and their use |
| 06/03/1999 | CA2310069A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor |
| 06/03/1999 | CA2309358A1 A-33 related antigens and their pharmacological uses |
| 06/03/1999 | CA2309341A1 Substituted .beta.-alanine derivatives as cell adhesion inhibitors |
| 06/03/1999 | CA2309204A1 1,3,4-thiadiazoles and 1,3,4-oxadiazoles as .alpha.v.beta.3 antagonists |
| 06/03/1999 | CA2303864A1 Inhibition of lipoprotein oxidation |
| 06/03/1999 | CA2255318A1 Combination therapy |
| 06/02/1999 | EP0919242A2 Method for administering acylated insulin |
| 06/02/1999 | EP0919234A2 Potentiation of pharmaceuticals by moxonidine |
| 06/02/1999 | EP0919232A1 Composition for use in the treatment and prevention of hyperuricemia |
| 06/02/1999 | EP0918761A1 Certain amido- and amino-substituted benzylamine derivatives; a new class of neuropeptite y1 specific ligands |
| 06/02/1999 | EP0918759A1 Novel thiazolidone-2 derivatives, 4-diketone substituted, method for obtaining them and pharmaceutical compositions containing same |
| 06/02/1999 | EP0918536A1 Composition comprising insulin and insulin-like growth factor-i (igf-i) |
| 06/02/1999 | EP0918515A2 USE OF INHIBITORS OF THE CELLULAR Na?+ /H?+ EXCHANGER (NHE) FOR PREPARING A MEDICAMENT FOR NORMALIZING SERUM LIPIDS |
| 06/02/1999 | EP0918455A1 Galanin |
| 06/02/1999 | EP0845036B1 Functional role of adrenomedullin (am) and the gene-related product (pamp) in human pathology and physiology |
| 06/02/1999 | EP0757718A4 Methods of use of uncoated gel particles |
| 06/02/1999 | CN1218462A Crystalline (-)-3R, 4R-trans-7-methoxy-2,2-dimetnyl-3-phenyl-4-{4-[2-(pyrrolidin-1-yl) ethoxy] phenyl} chromane, hydrogen fumarate |
| 06/02/1999 | CN1218460A Substituted 4-hydroxy-phenylalcanoic acid derivatives with activity to ppar-'gamma' |
| 06/02/1999 | CN1218409A Stimulation of host defence mechanisms against viral challenges |
| 06/02/1999 | CN1218397A Ethene containing solutions and use thereof in methods of therapy or prophylaxis |
| 06/02/1999 | CN1218395A Buccal delivery system |
| 06/02/1999 | CN1218049A Chromene derivatives and salts thereof, and pharmaceuticals containing the same |
| 06/02/1999 | CN1218047A Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 06/02/1999 | CN1218045A Imide derivatives or salts thereof |
| 06/01/1999 | US5908843 Thrombosis, antiinflammatory agent, arteriosclerosis, antitumor agents |
| 06/01/1999 | US5908837 Antiinflammatory agent |
| 06/01/1999 | US5908627 Antigen associated with Type I diabetes mellitus |
| 06/01/1999 | CA2142314C Method of reducing blood levels of total cholesterol and low-density lipoprotein cholesterol |
| 06/01/1999 | CA1340570C Process for synthesizing n-alkylated amino-acides and the esters thereof. their use for synthesizing carboxyalkyl dipeptides |
| 05/27/1999 | WO1999025728A1 Novel exendin agonist compounds |
| 05/27/1999 | WO1999025727A2 Novel exendin agonist compounds |
| 05/27/1999 | WO1999025709A1 Isoquinoline derivatives and their therapeutical use |
| 05/27/1999 | WO1999025707A1 2-ARYLBENZO[b]THIOPHENES USEFUL FOR THE TREATMENT OF ESTROGEN DEPRIVATION SYNDROME |
| 05/27/1999 | WO1999025706A1 2-aryl-3-aroylbenzo[b]thiophenes useful for the treatment of estrogen deprivation syndrome |
| 05/27/1999 | WO1999025362A1 Use of mixtures of active agents containing phytostenol for producing hypocholesteraemic preparations |
| 05/27/1999 | WO1999025361A1 Use of selected phytostenol esters for producing hypocholesteraemic preparations |
| 05/27/1999 | WO1999025348A1 5-ht1f agonists |
| 05/27/1999 | WO1999025337A1 Composition of ingredients for a beverage having a delayed aversion effect |
| 05/27/1999 | WO1999014346A3 SENSE mRNA THERAPY |
| 05/27/1999 | WO1999012961A8 Estrogen receptor |
| 05/27/1999 | DE19750453A1 Preparation of hypocholesterinemic agents |
| 05/27/1999 | CA2310248A1 5-ht1f agonists |
| 05/27/1999 | CA2310097A1 Novel exendin agonist compounds |
| 05/27/1999 | CA2310026A1 Hypocholesteremic preperations containing mixtures of phytostenol(ester)s and conjugated fatty acids, and methods of reducing serum cholesterol levels using the same |
| 05/27/1999 | CA2309905A1 Isoquinoline derivatives and their therapeutical use |
| 05/27/1999 | CA2309859A1 2-arylbenzo¬b|thiophenes useful for the treatment of estrogen deprivation syndrome |
| 05/27/1999 | CA2309824A1 2-aryl-3-aroylbenzo¬b|thiophenes useful for the treatment of estrogen deprivation syndrome |
| 05/27/1999 | CA2309325A1 Hypocholesteraemic preparations containing phytostenolesters of conjugated fatty acids, and methods of reducing serum cholesterol levels using the same |
| 05/26/1999 | EP0918059A1 Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them |
| 05/26/1999 | EP0917874A1 Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates |
| 05/26/1999 | EP0917587A1 A new method for producing pravastatin precursor, ml-236b |
| 05/26/1999 | EP0917572A2 Secreted proteins and polynucleotides encoding them |
| 05/26/1999 | EP0917537A1 Novel parathyroid hormone-related peptide analogs |
| 05/26/1999 | EP0917462A1 Cell adhesion inhibitors |
| 05/26/1999 | EP0772448A4 CYCLIC ANALOGS OF PTH AND PTHrP |
| 05/26/1999 | EP0752991B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONES ANTAGONISTS OF AMPA AND NMDA RECEPTORS |
| 05/26/1999 | EP0752988B1 5H-INDENO[1,2-b]PYRAZINE-2,3-DIONE DERIVATIVES ANTAGONISTS OF AMPA AND NMDA RECEPTORS |
| 05/26/1999 | EP0686625B1 Anthranilic acid derivative |
| 05/26/1999 | EP0630181B1 Nutritional product for trauma and surgery patients |
| 05/26/1999 | CN1217714A Substituted indazole derivatives and their use as inhibitors phosphodiesterase (PDE) type IV and production of tumor necrosis factor (TNF) |
| 05/26/1999 | CN1217327A D-proline derivative |
| 05/25/1999 | US5906988 Methods of treatment using ranolazine and related piperazine derivatives |
| 05/25/1999 | US5906979 Compositions and methods for treating metabolic diseases characterized by hyperandrogenism and/or anovulation and/or infertility |
| 05/25/1999 | CA2154257C Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
| 05/25/1999 | CA2138977C Cosmetic containing phospholipids and fluorocarbon compounds |
| 05/25/1999 | CA2120062C Use of sulodexide and of medicines containing it in the treatment of diabetic nephropathy |
| 05/25/1999 | CA2090574C Method of inhibiting nitric oxide formation |
| 05/25/1999 | CA2011452C Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7,17)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn -3-one |
| 05/20/1999 | WO1999024473A1 Antibodies against phosphorylated vasp (vasodilator-stimulated phosphoprotein), hybridoma cells for their preparation, and their use |
| 05/20/1999 | WO1999024450A2 Adensine a1 receptor agonists |
| 05/20/1999 | WO1999024421A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 05/20/1999 | WO1999024420A1 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 05/20/1999 | WO1999024408A1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 05/20/1999 | WO1999024406A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists |
| 05/20/1999 | WO1999024405A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type |
| 05/20/1999 | WO1999024404A1 Substituted pyridine compounds as anti-inflammatory agents |
| 05/20/1999 | WO1999024072A1 Release-sustaining agent for drugs and sustained-release pharmaceutical composition |
| 05/20/1999 | WO1999023996A2 Compositions containing red rice fermentation products, frementation processes and monascus strains therefor |
| 05/20/1999 | WO1999007736A3 Lipoprotein-regulating medicaments |
| 05/20/1999 | WO1998048785A9 Allelic polygene diagnosis of reward deficiency syndrome and treatment |
| 05/20/1999 | CA2309609A1 Imidazoylalkyl substituted with a five, six or seven membered heterocyclic ring containing one nitrogen atom |
| 05/20/1999 | CA2309597A1 Sustainedly releasing agents for medicines and sustainedly released medicinal compositions containing the same |
| 05/20/1999 | CA2309199A1 Adensine a1 receptor agonists |
| 05/20/1999 | CA2309177A1 Pyrimidinone compounds and pharmaceutical compositions containing them |
| 05/20/1999 | CA2309121A1 Phenyl-alkyl-imidazoles as h3 receptor antagonists |
| 05/20/1999 | CA2308586A1 H3 receptor ligands of the phenyl-alkyl-imidazoles type |
| 05/20/1999 | CA2308358A1 Heterocyclic compounds having mmp and tnf inhibitory activity |
| 05/19/1999 | EP0916670A2 Pyrrolo-(3,2-b) pyridines and their use as 5-HT1F agonists |